To further validate the expression of MMP1 between erlotinib sensitive and resistant NSCLC cells, 3 datasets were analyzed by GEO2R (|log2 (Fold change) | > 1 and P < 0.01) (Fig. 3b). The gene discussed is MMP1; the disease is non-small cell lung carcinoma.